Brief: Zydus Lifesciences Launches Biosimilar Aflibercept 2 Mg Anyra
Feb 19 (Reuters) - Zydus Lifesciences Ltd ZYDU.NS: LAUNCHES BIOSIMILAR AFLIBERCEPT 2 MG ANYRA SIGNS AGREEMENT WITH REGENERON AND BAYER Source text: ID:nBSE88q1Wr Further company coverage: ZYDU.NS ((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Zydus Lifesciences
See all newsIndia's Zydus Lifesciences posts lower profit as expenses outpace revenue growth
Brief: Zydus Lifesciences Q2 Consol Net Profit 9.26 Billion Rupees
Brief: Zydus Lifesciences Says Zylidac Bio And Prolific Machines Partner
Brief: Zydus Lifesciences Receives U.S. FDA Approval For Estradiol And Levonorgestrel Transdermal System
Brief: Zydus Lifesciences Says Zydus Sunshine Lifesciences Signs Agreement To Establish A Pharmaceutical Manufacturing Facility In Sri Lanka